☆ 4.7 Article

Signs and symptoms of COVID-19 in patients with multiple sclerosis

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Substance Abuse

Smoke Gets in the Eye: A systematic review of case reports of ocular complications of crack cocaine use

Hemant Gohil et al.

Summary: Issues related to the use of crack cocaine and its medical complications, such as 'crack eye', persist globally. A review of case reports found that most cases of 'crack eye' had bilateral involvement and the majority showed corneal infections. Aggressive treatment improved 95% of cases, but 23% were lost to follow-up, with 22% remaining with significant visual impairment.

DRUG AND ALCOHOL REVIEW (2022)

Add to Collection

Article Multidisciplinary Sciences

Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysis

Camille Jung et al.

Summary: This study retrospectively collected data from a university hospital in Paris to analyze the evolution of patient characteristics in different waves of COVID-19. The findings showed that the risk factors and protective factors in the first wave were different from the later waves, and the typology of hospitalized patients with severe forms rapidly evolved across the waves.

PLOS ONE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments

Raziyeh Najafloo et al.

Summary: The mechanism of anosmia in COVID-19 patients is multifaceted, involving factors such as inflammation, cell apoptosis, and odor transmission. Novel treatment strategies for long-term anosmia involve smart drug delivery, tissue engineering, and cell therapy to support efficient recovery of the olfactory system.

ACS CHEMICAL NEUROSCIENCE (2021)

Add to Collection

Article Allergy

Immunological imprint of COVID-19 on human peripheral blood leukocyte populations

Bernhard Kratzer et al.

Summary: The study revealed that COVID-19 convalescent patients still exhibit a range of immune system changes, including reduced neutrophils, increased activation of T cells, and elevated levels of specific antibodies even ten weeks after infection. Additionally, there were correlations found between these immunological changes and clinical/demographic parameters.

ALLERGY (2021)

Add to Collection

Article Clinical Neurology

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Maria P. Sormani et al.

Summary: This study assessed the impact of immunosuppressive and immunomodulatory therapies on the severity of COVID-19 in people with multiple sclerosis. Therapy with an anti-CD20 agent and recent use of methylprednisolone were associated with increased risk of severe COVID-19.

ANNALS OF NEUROLOGY (2021)

Add to Collection

Editorial Material Primary Health Care

Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth

Naomi A. van Westen-Lagerweij et al.

Summary: Recent studies have suggested that smokers may be protected against SARS-CoV-2 infection, as low percentages of smokers were found among COVID-19 patients. The article discusses the misinterpretation of observational research by scientists and the media, as well as the methodological flaws in various studies leading to hasty conclusions. It emphasizes the role of primary healthcare providers in correcting the erroneous claims about a protective effect of smoking.

NPJ PRIMARY CARE RESPIRATORY MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Lombardy, Northern Italy: COVID-19 second wave less severe and deadly than the first? A preliminary investigation

Andrea Borghesi et al.

Summary: Based on the study results, the second wave of COVID-19 appears to be less severe and deadly than the first wave, as evidenced by lower CXR severity of pneumonia, in-hospital mortality, and CRP levels.

INFECTIOUS DISEASES (2021)

Add to Collection

Article Otorhinolaryngology

COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts

Esha Sehanobish et al.

Summary: Younger patients and those with lower blood eosinophil counts were more likely to report anosmia and/or ageusia. Men were less likely to report ageusia, and time to taste recovery was faster among both men and Latino patients.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2021)

Add to Collection

Article Medicine, General & Internal

Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people

Joshua Elliott et al.

Summary: This study identified a set of 7 symptoms that can jointly predict COVID-19, including infection with the B.1.1.7 lineage, which helps maximize the detection of potential cases in the community.

PLOS MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Coronavirus disease 2019 in Latin American patients with multiple sclerosis

Yara D. Fragoso et al.

Summary: Patients with multiple sclerosis (MS) who have coronavirus disease 2019 (COVID-19) may face increased risks due to their neuroimmune condition and long-term immunomodulatory therapies. A study of 73 MS patients with confirmed COVID-19 in Latin America found that the use of anti-CD20 therapies was the only risk factor associated with hospitalization and death. Despite the small sample size, this study highlights the importance of considering therapeutic options for MS patients during the pandemic.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Add to Collection

Review Clinical Neurology

Multiple sclerosis and COVID-19: The Swedish experience

Anne-Marie Landtblom et al.

Summary: The COVID-19 pandemic has posed challenges for healthcare management of MS patients, with concerns raised about susceptibility to infections and DMTs use. Sweden has established national guidelines for DMTs use and implemented a COVID-19 module. Telemedicine consultations and PROMs have played significant roles in MS healthcare during this period.

ACTA NEUROLOGICA SCANDINAVICA (2021)

Add to Collection

Letter Infectious Diseases

First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?

Manuel Taboada et al.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Clinical Neurology

The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

S. Sen et al.

Summary: The study investigated the incidence of Covid-19 in patients with Multiple Sclerosis (pwMS) and the relationship between demographic-clinical features, treatment, and Covid-19 outcomes. The results showed that pwMS, being a younger population with fewer comorbidities, do not face a higher risk of severe COVID-19 outcomes regardless of the disease-modifying therapy they are receiving. No significant association of DMTs with Covid-19 severity was detected in the study.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Add to Collection

Review Clinical Neurology

COVID-19 Among Patients With Multiple Sclerosis A Systematic Review

Mahdi Barzegar et al.

Summary: During the COVID-19 pandemic, patients with MS had a lower infection rate and did not significantly increase mortality rate after contracting the disease. The most common symptoms were fever, cough, and fatigue. Specific treatment methods may affect the hospitalization and mortality rates of patients.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Add to Collection

Article Dermatology

The effects of alcohol and illicit drug use on the skin

Neelesh P. Jain et al.

Summary: Early identification of cutaneous manifestations of alcohol and illicit drug use can aid in diagnosis and management, reducing the risk of sequela. The effects of alcohol and illicit drug use on the skin can result in significant morbidity.

CLINICS IN DERMATOLOGY (2021)

Add to Collection

Article Immunology

Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March-April 2020

Kristen Pettrone et al.

Summary: The study found that the risk of hospitalization for patients with coronavirus disease in Atlanta, Georgia, was higher in older patients and those with multiple comorbidities. There was also a potential link between hospitalization and high hemoglobin A1c levels in individuals with diabetes.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Letter Medicine, General & Internal

Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)

Giuseppe Lippi et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

Add to Collection

Review Virology

The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis

Qianwen Zhao et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Clinical Neurology

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Celine Louapre et al.

JAMA NEUROLOGY (2020)

Add to Collection

Article Infectious Diseases

Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy

Antonio Vena et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Add to Collection

Review Pharmacology & Pharmacy

COVID-19: A review of the proposed pharmacological treatments

Sarah Lam et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders in 1942 nonhospitalized patients with coronavirus disease 2019 (COVID-19)

Radoslaw Sierpinski et al.

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2020)

Add to Collection

Review Pharmacology & Pharmacy

Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis

Konstantinos Farsalinos et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)

Add to Collection

Review Medicine, General & Internal

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease

Thomas Struyf et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM

Oscar Fernandez et al.

CLINICAL THERAPEUTICS (2017)

Add to Collection

Review Clinical Neurology

Disease-modifying therapies and infectious risks in multiple sclerosis

Alexander Winkelmann et al.

NATURE REVIEWS NEUROLOGY (2016)

Add to Collection

Article Psychology, Clinical

Unawareness of Olfactory Dysfunction and its Association with Cognitive Functioning in Middle Aged and Old Adults

Eike Wehling et al.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2011)

Add to Collection

Article Medicine, Research & Experimental

Loss of smell (Anosmia) and taste (Ageusia) in a patient treated with pegylated interferon alfa and ribavirin

Ahmed Yacoob Mayet

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.